Predicting severity of community-acquired pneumonia with AMBU-65/CURB-65 sc - Evidencio
Predicting severity of community-acquired pneumonia with AMBU-65/CURB-65 score (copy)
Prediction tool to define community acquired pneumonia severity on presentation to hospital, recommended by the British Thoracic Society. 
Forschungsautoren: Lim W, van der Eerden MM, Laing R, Boersma W, Karalus N, Town G, Lewis S, and Macfarlane J.
Version: 1.2
  • Öffentlich
  • Pulmonologie
  • Lineare Regression
  • Details
  • Algorithmus validieren
  • Eingabe speichern
  • Eingabe laden
  • Englisch Niederländisch

Confusion

Urea level

1
50
mmol/L

Respiratory rate

5
50
bpm

Systolic blood pressure

50
250
mmHg

Diastolic blood pressure

25
150
mmHg

Age

18
100
years

Calculated CURB-65/AMBU-65 score: ... points

Setzt alle Parameter, um die Vorhersage zu berechnen.

How this model should be used:
The CURB-65/AMBU-65 model is a one step strategy for stratifying patients with CAP into risk groups according to risk of mortality at 30 days.1

  • Patients with CURB-65 scores 0 and 1 are at low risk of mortality (<2%) and might be suitable for management as hospital outpatients or by their general practitioner.
  • Patients with a score of 2 are at intermediate risk of mortality (9%) and should be considered for hospital supervised treatment.
  • Patients with  a score >2 are at high risk of mortality (>19%) and should be treated in hospital. Initial care in an intensive care or high dependency unit may be appropriate in those with the highest scores.
Note:
Although low serum albumin was identified as a strong independent prognostic variable in addition to the CURB score for predicting 30 day mortality, it was not included in the final model as it is not a routinely available test in many hospitals. If serum albumin level is at your disposal, you might consider using a more extended model including serum albumin.

Source:
  1. Lim WS, van der Eerden MM, Laing R, et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax. 2003;58(5):377-82.

Dieses Algorithmus wird zu Bildungs-, Schulungs- und Informationszwecken bereitgestellt. Es darf nicht zur Unterstützung der medizinischen Entscheidungsfindung oder zur Erbringung medizinischer oder diagnostischer Leistungen verwendet werden. Lesen Sie unseren vollständigen disclaimer.

Neueste algorithmen
Kommentare

Algorithmus-Feedback

Noch keine Rückmeldung
logo

Bitte melden Sie sich an, um die Evidencio-Druckfunktionen zu aktivieren

Um die Evidencio-Druckfunktionen nutzen zu können, müssen Sie angemeldet sein.
Wenn Sie keinen Evidencio-Community-Account besitzen, können Sie sich kostenlos ein persönliches Konto erstellen:

https: // www. evidencio.com/registration

Gedruckte Ergebnisse - Beispiele {{ new Date().toLocaleString() }}


Vorteile des Evidencio-Community-Kontos


With an Evidencio Community account you can:

  • Create and publish your own prediction algorithms.
  • Share your prediction algorithms with your colleagues, research group, organization or the world.
  • Review and provide feedback on algorithms that have been shared with you.
  • Validate your algorithms and validate algorithms from other users.
  • Find algorithms based on Title, Keyword, Author, Institute, or MeSH classification.
  • Use and save prediction algorithms and their data.
  • Use patient specific protocols and guidelines based on sequential algorithms and decision trees.
  • Stay up-to-date with new algorithms in your field as they are published.
  • Create your own lists of favorite algorithms and topics.

A personal Evidencio account is free, with no strings attached!
Join us and help create clarity, transparency, and efficiency in the creation, validation, and use of medical prediction algorithms.


Disclaimer: Berechnungen allein sollten niemals die Pflege der Patienten vorschreiben und ersetzen kein professionelles Urteilsvermögen.
Evidencio v3.36 © 2015 - 2025 Evidencio. Alle Rechte vorbehalten